Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol

Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol

Introduction SARS-CoV-2 (COVID-19) has caused an international pandemic of respiratory illness, resulting in significant healthcare and economic turmoil. To date, no robust vaccine or treatment has been identified. Elemental zinc has previously been demonstrated to have beneficial effects on coronav...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Marlon Perera, Christine F McDonald, Liang Qu, Rinaldo Bellomo, Paul Johnson, Jason Trubiano, John El Khoury, Vidyasagar Chinni, Damien Bolton, Daryl Jones, Oneel Patel, Joseph Ischia
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: BMJ Publishing Group 2020-12-01
Σειρά:BMJ Open
Διαθέσιμο Online:https://bmjopen.bmj.com/content/10/12/e040580.full

Διαδίκτυο

https://bmjopen.bmj.com/content/10/12/e040580.full

Παρόμοια τεκμήρια